ALCATEL LUCENT SA 01/06/2010 Combined
1To approve the parent company's financial statements, and appove its non deductible expenses.For
2To approve consolidated financial statementsFor
3To approve the appropriation of incomeFor
4To re-elect Mr Philippe Camus as Director for a period of 4 years (3 years subject to the approval of resolution 32).Abstain
5To re-elect Mr Ben Verwaayen as Director for a period of 4 years (3 years subject to the approval of resolution 32).For
6To re-elect Mr Daniel Bernard as Director for a period of 4 years (3 years subject to the approval of resolution 32).For
7To re-elect Mr Franck Blount as Director for a period of 4 years (3 years subject to the approval of resolution 32).Oppose
8To re-elect Mr Stuart E. Eizenstat as Director for a period of 4 years (3 years subject to the approval of resolution 32).For
9To re-elect Mr Louis R. Hugues as Director for a period of 4 years (3 years subject to the approval of resolution 32).For
10To re-elect Mr Jean C. Monty as Director for a period of 4 years (3 years subject to the approval of resolution 32).For
11To re-elect Mr Olivier Piou as Director for a period of 4 years (3 years subject to the approval of resolution 32).For
12To elect Mrs Carla Cico as Director for a period of 4 years (3 years subject to the approval of resolution 32).For
13To approve directors fees of € 990,000 in addition to a compulsory investment of € 200,000 i.e. about 90,000 Alcatel Lucent sharesFor
14Re-election of Jean-Pierre Desbois as non voting Director for a period of 2 years.Oppose
15To appoint Mr Bertrand Lapraye as non voting Director for a period of 2 yearsOppose
16To approve regulated related-party agreementsFor
17 To approve commitments referred to in the special report of auditors and granted to Mr Philippe CamusOppose
18To approve commitments referred to in the special report of auditors and granted to Mr Ben VerwaayenOppose
19To amend By-laws : relocate Corporate HeadquartersFor
20To approve buy-back of the company sharesFor
21To approve potential reduction of the company 's capitalFor
22Global authorisation to increase the capital up to € 920 000 000 with pre-emptive subscription rightFor
231)Global allowance to issue capital related securities without pre-emptive right by public offering ;

2)To approve issuance by subsidiary companies of securities offering access to the company's capital stock by public offering ;

3)To approve issues of shares or other capital related securities as a payment for any public offer by public offering

Oppose
24Global allowance to issue capital related securities without pre-emptive right by private placementOppose
25"Green shoe" authorizationOppose
26Delegation to issue shares and capital securities as consideration for contributions in kind made to the companyOppose
27To limit capital increases with or without pre-emption rightsFor
28To authorise capital increase by transfer of reservesFor
29To issue restricted shares for employees and managersFor
30To approve issuance of new stock option plans (new issued or treasury stock)Oppose
31To approve capital Increase for employees who contracted a corporate savings planFor
32To amend By-laws on term of directors mandatesFor
33Delegation of powers for the completion of formalitiesFor